Funding for this research was provided by:
Astellas Pharma Global Development (N/A)
Received: 8 October 2019
Accepted: 14 February 2020
First Online: 18 March 2020
Ethics approval and consent to participate
: The study protocol was reviewed by an Independent Ethics Committee/Institutional Review Board for the study sites. Approval for the study protocol was obtained from the relevant competent authority prior to study initiation. Institutional Review Board/Independent Ethics Committee-approved written informed consent was obtained from all participants or their legally authorized representative prior to any study-related procedures.
: Not applicable as no individual data are reported, all data has been anonymized and participants are not identifiable.
: TLG is a consultant for Astellas, and has received grants from the National Institute on Aging and the National Institutes of Health. NLC is a consultant for Astellas. JM has received grants from Astellas. DS has received grants and personal fees for services as an investigator, consultant, and speaker for Astellas. SH has received grants from Allergan, Astellas, Ipsen, and Ixaltis, and personal fees from Allergan, Astellas, and Pfizer. DE and CRS are employees of Astellas Pharma Global Development, Inc.